Abstract:Background Polyethyleneimine (PEI), which can interact with negatively charged DNA through electrostatic interaction to form nanocomplexes, has been widely attempted to use as a gene delivery system. However, PEI has some defects that are not fit for keeping on gene expression. Therefore, some modifications against PEI properties have been done to improve their application value in gene delivery. In this study, three modified PEI derivatives, including poly(ε-caprolactone)-pluronic-poly(ε-caprolactone) grafted PEI (PCFC-g-PEI), folic acid-PCFC-isophorone diidocyanate-PEI (FA-PEAs) and heparin-PEI (HPEI), were evaluated in terms of their cytotoxicity and transfection efficiency in vitro and in vivo in order to ascertain their potential application in gene therapy. Methods MTT assay and a marker GFP gene, encoding green fluorescent protein, were used to evaluate cell toxicity and transfection activity of the three modified PEI in vitro . Renal cell carcinoma (RCC) models were established in BALB/c nude mice inoculated with OS-RC-2 cells to detect the gene therapy effects using the three PEI-derived nanoparticles as gene delivery vehicles. The expression status of a target gene Von Hippel-Lindau (VHL) in treated tumor tissues was analyzed by semiquantitative RT-PCR and immunohistochemistry. Results Each of three modified PEI-derived biomaterials had an increased transfection efficiency and a lower cytotoxicity compared with its precursor PEI with 25-kD or 2-kD molecule weight in vitro . And the mean tumor volume was obviously decreased 30% by using FA-PEAs to transfer VHL plasmids to treat mice RCC models. The VHL gene expression was greatly improved in the VHL-treated group. While there was no obvious tumor inhibition treated by PCFC-g-PEI:VHL and HPEI:VHL complexes. Conclusions The three modified PEI-derived biomaterials, including PCFC-g-PEI, FA-PEAs and HPEI, had an increased transfection efficiency in vitro and obviously lower toxicities compared with their precursor PEI molecules. The FA-PEAs probably provide a potential gene delivery system to treat RCC even other cancers in future.

Novel Polyethyleneimine-R8-heparin Nanogel for High-Efficiency Gene Delivery in Vitro and in Vivo.

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Poly(ethylene Glycol)-Poly-l-glutamate Complexed with Polyethyleneimine-Polyglycine for Highly Efficient Gene Delivery in Vitro and in Vivo.

In Vitro and in Vivo Gene Delivery Using Polyethylenimine-Poly(hydroxyethyl Glutamine) As a Non-Viral Carrier.

Hyperbranched PEI grafted by hydrophilic amino acid segment poly[N-(2-hydroxyethyl)- L -glutamine] as an efficient nonviral gene carrier

Enhanced Gene Transfection Efficacy and Safety Through Granular Hydrogel Mediated Gene Delivery Process

Comparisons of Three Polyethyleneimine-Derived Nanoparticles As a Gene Therapy Delivery System for Renal Cell Carcinoma

Enzyme-responsive Charge-Reversal Polymer Mediated Effective Gene Therapy for Intraperitoneal Tumors

Novel Gelatin-Siloxane Nanoparticles Decorated By Tat Peptide As Vectors For Gene Therapy

Hydrophobic Poly (amino Acid) Modified PEI Mediated Delivery of Rev-Casp-3 for Cancer Therapy.

Antitumoral Efficacy By Systemic Delivery Of Heparin Conjugated Polyethylenimine-Plasmid Interleukin-15 Complexes In Murine Models Of Lung Metastasis

Surface modification of TPGS- b -(PCL- ran -PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy

Polylysine-modified Polyethylenimine Inducing Tumor Apoptosis As an Efficient Gene Carrier

Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.

Biocompatible Polyethylenimine-Graft-Dextran Catiomer for Highly Efficient Gene Delivery Assisted by A Nuclear Targeting Ligand

Polyethyleneimine Grafted Short Halloysite Nanotubes for Gene Delivery.

Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma

Injectable Supramolecular Hydrogels As Delivery Agents of Bcl‐2 Conversion Gene for the Effective Shrinkage of Therapeutic Resistance Tumors

Arginine-rich Peptide Based Nanoparticles with Bridge-Like Structure: Enhanced Cell Penetration and Tumor Therapy Effect

Virus-esque nucleus-targeting nanoparticles deliver trojan plasmid for release of anti-tumor shuttle protein.

Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-γ-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector